IP Group plc’s Post

View organization page for IP Group plc, graphic

7,568 followers

Great news today from portfolio company Microbiotica , which has announced it has received regulatory approvals in the EU and UK to initiate Phase 1b clinical studies for its live biotherapeutic products (LBPs) in advanced melanoma (MELODY-1: MB097) and ulcerative colitis (COMPOSER-1: MB310). Congratulations to the whole team on this huge milestone! Read more here: https://bit.ly/4e11tiS #biotech #melanoma #ulcerativecolitis

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics